Adnet, Author at Rapid Dose Therapeutics

Latest News

May 26, 2022
Rapid Dose Therapeutics Corp Announces Proposed Private Placement

View News Release View PDF

May 25, 2022
Rapid Dose Therapeutics Closes First Tranche of Private Placement

View News Release View PDF

May 12, 2022
Rapid Dose Therapeutics Provides Shareholder Update Regarding Vaccine Collaboration Agreement with Oakland Health Limited in the United Kingdom

View News Release View PDF

April 26, 2022
Rapid Dose Therapeutics and Skycare Compounding Labs to Provide Patients with a Novel Oral Delivery Option for Pharmaceutical Products

View News Release View PDF

March 7, 2022
RD Therapeutics and Rapid Dose Therapeutics Participate in the CEPI Global Pandemic Preparedness Summit and Support the #100DaysMission — the value of needle-free vaccination, such as the QuickStrip™, will be discussed.

View News Release View PDF

February 10, 2022
Rapid Dose Therapeutics Announces Management Change

View News Release View PDF

January 5, 2022
Rapid Dose Therapeutics Appoints Dr. Michael Glogauer to Advisory Board

View News Release View PDF

December 22, 2021
Rapid Dose Therapeutics and McMaster University’s COVID-19 Vaccine Study Receives NSERC Research and Development Grant

View News Release View PDF

December 15, 2021
Rapid Dose Therapeutics Strengthens Leadership Team with Addition of Rodney Butt & Appoints New Advisory Board Member

View News Release View PDF

December 9, 2021
Rapid Dose Therapeutics Signs Product Supply Agreement with Oakland Health Limited in the United Kingdom

View News Release View PDF